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SUMMARY 
Objective: To establish a set of clinical and paraclinical criteria potentially useful as a diagnostic 
screening tool for polyarteritis nodosa (PAN).  
Methods: The abilities of individual descriptive items to predict PAN diagnosis were evaluated by 
screening available data for 949 patients entered in the French Vasculitis Study Group’s (FVSG) 
database, including 262 with PAN and 687 control vasculitides. Selected items were tested in a 
logistic-regression model to establish a minimal set of non-redundant PAN predictive criteria. The 
discriminative accuracy of these items and of 1990 ACR criteria were assessed by reapplying them 
to the initial patient sample and a subgroup restricted to PAN and microscopic polyangiitis (MPA) 
patients. A computer-simulation procedure was conducted on artificially generated patient data 
to evaluate the usefulness of these criteria to predict PAN diagnosis. 
Results: The analysis retained 3 positive-predictive (HBV-antigen and/or DNA in serum, 
arteriographic anomalies, mono- or polyneuropathy) and 5 negative-predictive parameters 
(indirect immunofluorescence ANCA detection, asthma, ENT signs, glomerulopathy, and 
cryoglobulinemia), yielding 70.6% sensitivity for all control vasculitides and 89.7% for MPA 
controls, with 92.3% specificity for all controls and 83.1% for MPA. The discriminant abilities of 
this set of items outperformed the 1990 ACR criteria in all analytical situations, showing better 
robustness to variations in the prevalence of individual vasculitides. 
Conclusion: The use of positive and negative discriminant criteria could constitute a sound basis 
for developing a PAN diagnostic tool for clinicians. Further prospective analyses and validations in 
different populations are needed to confirm these items as satisfactory diagnostic criteria. 
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INTRODUCTION 
Systemic vasculitides are a heterogeneous group of diseases that have blood-vessel inflammation 
as a common trait. In 1990, relying on many previous efforts, the American College of 
Rheumatology (ACR) proposed a set of classification criteria, selected by a panel of experts based 
on an analysis of multicenter patient data (1). Seven distinct entities were thus characterized, 
including polyarteritis nodosa (PAN) (2). Although the primary purpose of the 1990 ACR criteria 
was to standardize classification of vasculitis patients to facilitate communication among 
researchers (3), their good discriminative accuracy indicated by the initial assessments, with 
sensitivities between 71–94% and specificities between 87–92% for different types of 
vasculitides, suggested a potential usefulness for diagnostic prediction (4). However, subsequent 
evaluations of the set of 1990 ACR criteria used for diagnostic screening under routine clinical 
conditions yielded inconstant and unsatisfactory results, with positive-predictive values ranging 
from 17% to 75% for different types of vasculitides and high percentages of false positive 
diagnoses (4). Further assessments, extended to other classification systems, like the Chapel Hill 
Nomenclature (5, 6) were equally disappointing, highlighting the necessity to develop separate 
criteria for classification and diagnostic purposes (7). 
We conducted a prospective analysis of the French Vasculitis Study Group (FVSG) patient 
database, intended to evaluate the feasibility of establishing a minimal set of predictive clinical 
and paraclinical features, which could serve as a screening tool for PAN diagnosis in situations in 
which the clinical picture is suggestive of systemic vasculitis. Because the 1990 ACR criteria do not 
distinguish between PAN and microscopic polyangiitis (MPA), formally defined by the Chapel Hill 
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Nomenclature in 1992 (8), a secondary objective of our analysis was to achieve better 
discrimination between PAN and MPA. 
METHODS 
The analytical design comprised two distinct stages. The first stage was to select a minimum set 
of low redundant positive and/or negative PAN predictive items, among those exhibiting the 
highest individual accuracy in distinguishing PAN from other systemic vasculitides. The selection 
of this set relied on clinical judgment supported by a combination of uni- and multivariate 
statistical analysis of clinical and paraclinical items used to describe patient characteristics in the 
FVSG database. During the second stage, the PAN-predictive abilities of the selected set of criteria 
were evaluated through an unsupervised computer-simulation procedure, designed to reproduce 
the case-based aspect of the clinical diagnostic reasoning. Both analytical stages were compared 
to the 1990 ACR classification criteria considered to be the most reliable reference to date. 
Analysis of capabilities of available clinical and paraclinical items to predict PAN 
The FVSG patient database contains a large set of clinical and paraclinical items, designed to 
describe systemic vasculitides characteristics with a good level of detail. Our analysis relied on 
patient information extracted from the FVSG database, after filtering for missing items and 
secondary vasculitides associated to other systemic diseases, like rheumatoid arthritis (RA) and 
systemic lupus erythematosus (SLE). This procedure selected 949 patients with primary systemic 
vasculitides for which definitive diagnostic evidence was available; in all cases diagnoses were 
based on compatible clinical manifestations, biochemical parameters including antineutrophil 
cytoplasm antibody (ANCA) testing, histology, and, when available, angiograms. The histological 
confirmation of the clinical diagnosis relied on the same elements as those used by the 1990 ACR 
H
AL author m
anuscript    inserm
-00276487, version 1
  
5 
analysis (1, 2), and was a mandatory selection criterion, used only as diagnostic reference to 
ensure a reliable assessment of the available clinical and paraclinical items. 
The selected patient sample had the following distribution of vasculitis types: 262 (27.6%) 
with PAN, among whom 108 had hepatitis B virus (HBV)-related PAN (41.2% of all PAN), 256 
(27%) with Wegener’s granulomatosis (WG), 207 (21.8%) with MPA, 150 (15.8%) with Churg–
Strauss syndrome (CSS), 18 (1.9%) with cryoglobulin-associated vasculitis and 56 (5.9%) with 
other primary systemic vasculitides. 
Analysis of these data, in the search for a minimal set of low-redundant PAN predictive 
items, was conducted in two steps. During a first step, the entire list of over 100 clinical and 
paraclinical items used to describe patient characteristics in FVSG database, including all the 1990 
ACR criteria, was subjected to univariate analysis to assess the individual discriminative value of 
each available feature. Among these items, the presence of HBV surface antigen, one of the 1990 
ACR criteria, was replaced by markers reflecting active HBV replication, such as the detection of 
HBV e-antigen (HBeAg) and/or DNA >105copies/mL in serum (9). An indirect immunofluorescence 
assay (IIF) was used to test for ANCA according to European Vasculitis Study (EUVAS) group 
recommendations (10). Because ANCA specificity (anti-myeloperoxidase or proteinase 3) was not 
systematically determined, it was ignored.  
The univariate analysis assessed the strength of individual associations between PAN 
diagnosis and available clinical or paraclinical features by relying on a normalized, pairwise, 
mutual information (MI) measure, which is a well-established entropic approach for quantifying 
mutual dependence (e.g. positive or negative) between variables (11). A short presentation of the 
MI measure is provided online as supplementary data, together with other formal aspects 
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pertaining to the analytical strategy of the study (12). The univariate analysis enabled 
quantification of the usefulness of the information provided by each clinical and paraclinical item 
to diagnose PAN, and allowed to rank available items by the decreasing order of their PAN-
predictive value.  
To establish a minimal set of low-redundant PAN-predictive criteria we conducted an 
exploratory multivariate analysis that relied on available parameters to build a logistic-regression 
model through a forward inclusion approach based on the R2 criterion. The inclusion procedure 
was directed by clinical judgment and the PAN-predictive value of individual items, as determined 
by the univariate analysis, and was reiterated until the logistic-regression model could no longer 
be significantly improved by further inclusion of additional items. This analysis was conducted in 
two distinct situations, one in which all non-PAN vasculitides were considered as controls, and 
the second in which controls were restricted to MPA in order to favor the selection of 
discriminant items capable to distinguish between PAN and MPA not differentiated by the 1990 
ACR analysis. Also, taking into consideration the current trend of reduction of the incidence of 
HBV infection, induced by systematic vaccination programs, and its diminishing association with 
PAN, the discriminant performances of these criteria were separately evaluated on a subgroup of 
vasculitides including only HBV-negative PAN. 
The resulting FVSG set of criteria, selected by the multivariate analysis, was further used 
to derive a set of relevant positive and negative association rules, based on an implementation 
(13) of a decision-tree inference algorithm (14), designed to optimize the ratio between 
diagnostic prediction accuracy and its cost (e.g. the number of required items). This analysis was 
undertaken to devise a tool for future clinical use of this criteria by exposing the most relevant 
association rules between selected items. Finally, the PAN-predictive accuracy of the FVSG set of 
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criteria and the 1990 ACR classification criteria were comparatively assessed, in terms of 
sensitivity and specificity, by receiver operating characteristics (ROC) curve analysis (15), in each 
of the above-mentioned analytical situations.  
Computer simulation of PAN-predictive abilities of FVSG and 1990 ACR criteria  
During the second analytical stage, computer simulations were run to evaluate the PAN-
predictive abilities of the two sets of criteria under various conditions simulated through 
artificially generated vasculitis patient data. The computer-simulation procedure was designed to 
reproduce the case-based reasoning aspect of medical diagnostic reasoning, which attempts to 
ascribe unambiguous labels (e.g. corresponding to distinct pathological entities) to clusters of 
cases with similar clinical and paraclinical features. The aim of this simulation was to test the 
dependence of the PAN-predictive performances of these sets on the prevalence of individual 
vasculitides in the analyzed patient samples. The Boolean aspect of the presence or absence of 
clinical and paraclinical features in vasculitis patients suggested the possibility of relying on a 
model of aggregated dependent Bernoulli trials to represent the real joint distributions of the 
clinical and paraclinical parameters specific to each vasculitis. To ensure a good reproducibility of 
the computer-simulation results we considered two distinct approaches to quantify and express 
marginal distributions and dependencies between individual parameters. 
The first approach relied on the Bahadur–Lazarsfeld theoretical framework, which 
computes a complete representation of the joint distribution of a set of n  correlated Bernoulli 
trials (e.g. corresponding to n clinical or paraclinical items) through an expansion of a binomial 
law (16). A short formal presentation of the Bahadur–Lazarsfeld framework is provided online as 
supplementary data (12). Despite its good theoretical accuracy, a major drawback of the 
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Bahadur–Lazarsfeld expansion is its requirement of a high number of dependency parameters 
(e.g. correlation parameters expressing dependencies between Bernoulli trials from the 2nd to the 
nth order), which challenges the computational tractability of the model, even for a moderate 
number of trials. These considerations suggested the usefulness of a recently proposed 
theoretical solution, which relies on the maximum entropy principle to optimize the inference of 
missing parameters of a truncated Bahadur–Lazarsfeld expansion (e.g. which considers as input 
parameters only marginal probabilities and second-order correlations) (17), thereby allowing to 
achieve a highly precise reproduction of the clinical and paraclinical characteristics of real 
vasculitis patients in artificially generated data. The required marginal probabilities and the 
second-order correlations between clinical and paraclinical items were computed from the 
patient sample extracted from the FVSG database. 
The second approach used to generate artificial patient data relied on a maximum-
spanning tree (MST) dependence-modeling technique, which approximates dependencies 
between individual parameters by arbitrarily limiting them to those expected to have the most 
impact on the results (18, 19). The principle of the MST dependence-modeling technique resides 
in estimating the joint distribution of item presence by relying on an MST representation of their 
strongest interdependencies. Further details are provided online as supplementary data (12). The 
marginal probabilities of clinical and paraclinical items and the pairwise MI coefficients, required 
by the MST approach, were computed from the FVSG patient sample. 
The generation of artificial vasculitis patient data aimed to reflect two types of situations. 
The first was a reference situation, in which patient data were artificially generated by using 
either the maximum entropy correction of a truncated Bahadur–Lazarsfeld extension or the MST 
method to simulate intricate interdependencies between various clinical and paraclinical 
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parameters seen in the FVSG patient database. In this situation the relative frequencies of the 
four main types of vasculitides represented within artificially generated patient samples were 
chosen to reflect the prevalence reported in the French population: 34.03% PAN, 27.83% MPA, 
26.27% WG, and 11.86% CSS (20). In the second situation, the relative frequencies of PAN cases 
were modified to test the effect of variations in vasculitis-prevalence on predictive performances 
of the two sets of criteria. To this purpose the relative frequency of PAN patients was arbitrarily 
reduced to 10% of all generated cases, while increasing relative frequencies of the other three 
vasculitides to 30% for each.  
The artificial patient data, thus generated, was further used in a computer simulation to 
evaluate the usefulness of the two sets of criteria when used to screen potential vasculitis 
patients for positive PAN diagnosis. To achieve this goal, we relied on a combination of an 
unsupervised hierarchical clustering approach, used to group artificially generated cases based on 
the similarities of their clinical and paraclinical profiles, and a supervised labeling procedure, 
which assigns to each resulting cluster of similar cases the true label of the cases that form the 
majority of its content. 
The clustering approach starts by grouping the two most similar cases together to form a 
first cluster, and then reiterates the agglomerative procedure until all cases are collected in a 
single cluster, thereby generating a new partition of cases into clusters at each iterative step. The 
choice of the optimal partition of clusters (e.g. reflecting the actual distribution of distinct 
pathological entities in the analyzed patient data) is a fundamental issue in unsupervised 
learning. A popular solution to this problem is to simplify it by finding the partition that provides 
the best trade-off between the homogeneity of the clusters and their isolation on the partition 
(21). Although there is no best approach to fit all situations, the computation of the Silhouette 
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index, a well-understood partition quality indicator, was shown to be a simple yet robust strategy 
for predicting optimal clustering partitions (12, 22).  After identifying the optimal partition and 
labeling its clusters, the predictive abilities of the two sets of criteria were evaluated by 
computing estimations of sensitivity, specificity, and of positive- and negative-predictive values 
from the contingency table reflecting the attribution of cases to each vasculitis type. The 
differences between the estimated performances of the ACR and FVSG sets, computed from 30 
independent iterations of the simulation procedure, were assessed for statistical significance with 
a chi-square test comparing distributions of discrete variables, and a paired Student’s t-test to 
evaluate mean values from continuous distributions. All statistical analyses and simulations were 
conducted by using SPSS version 13.0 (SPSS Inc., Chicago IL), and the R software environment for 
statistical computing (23). 
RESULTS 
The logistic-regression analysis, performed while considering all non-PAN vasculitides as controls, 
retained a set of 8 minimally redundant PAN-predictive items (table 1), including 3 positive and 5 
negatively associated parameters (table 2A). When restricted to the subgroup of HBV-negative 
PAN, this analysis confirmed the PAN-predictive abilities of one positive and 5 negatively 
associated parameters (table 2B). Combining these items yielded sensitivities of 70.6% for all 
forms of PAN and 76.6% for HBV-negative PAN, with specificities of 92.3% and 88.9% 
respectively. When controls were restricted to MPA alone, the non-redundant PAN-predictive 
abilities were confirmed only for 4 of the previously identified items, 2 were positively associated 
with PAN diagnosis, and 2 were more frequent in MPA (table 2A). One positive and 2 negatively 
associated parameters (table 2B), showed significant non-redundant PAN-predictive abilities 
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when considering only the subgroup of HBV-negative PAN. The combined sensitivity of these 
items was 89.7% for all forms of PAN and 83.1% for HBV-negative PAN cases, with specificities of 
83.1%, and 83.6% respectively. 
The logistic-regression analysis confirmed the abilities of 7 items from the 1990 ACR 
classification criteria to identify PAN (table 3A). However, the positive association with PAN 
diagnosis, indicated by the 1990 ACR analysis, could not be confirmed for one item (renal 
insufficiency), which occurred more frequently in non-PAN vasculitides. These 7 criteria yielded a 
combined sensitivity of 48.9%, with 95.6% specificity when all other vasculitides served as 
controls. When considering only the subgroup of HBV-negative PAN cases and all other non-PAN 
vasculitides as controls, the non-redundant PAN-predictive abilities of the 1990 ACR criteria were 
confirmed only for 4 positive and one negatively associated parameters (table 3B), resulting in a 
major decrease of sensitivity to 8.4%, with 98% specificity in this situation. When controls were 
restricted to MPA, the discriminant abilities of non-redundant PAN items were confirmed only for 
3 of them (table 3A), 2 of which were positively associated with PAN diagnosis, while one (renal 
insufficiency) occurred more frequently in MPA. In the latter settings the 3 discriminant items 
yielded 50.8% sensitivity for all forms of PAN, with 96.1% specificity. One positive and one 
negatively associated parameters (table 3B), showed significant non-redundant PAN predictive 
abilities when considering only the subgroup of HBV-negative PAN, yielding 12.3% sensitivity, 
with 99% specificity in this situation. 
The two sets of association rules established from selected FVSG set of criteria are 
presented in table 4. When all other vasculitides served as controls 4 positive and 5 negative 
association rules could be established, based on 7 of the 8 previously selected features (excepted 
asthma), giving this model a combined sensitivity of 70.2%, with 88.2% specificity. When the 
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controls were restricted to MPA, 3 positive and 2 negative association rules were established, 
including all the 4 features identified by the logistic-regression analysis (table 4). 
ROC curve analyses performed considering all other vasculitides as controls (fig 1A) 
yielded areas under the curves of 0.916 [0.898–0.934] for the FVSG selected items and 0.711 
[0.671–0.750] for the 1990 ACR criteria, confirming significantly better discriminant accuracy of 
the FVSG item set (p-value <0.05). The asymptotic significance for these curves was acceptable 
for both sets of criteria (p-value <0.001). When controls were restricted to MPA (fig 1B), ROC 
curve analyses yielded areas under the curves of 0.906 [0.878–0.934 ] for the selected FVSG 
criteria, and 0.588 [0.537–0.639] for the 1990 ACR criteria, thereby confirming significantly better 
predictive accuracy of the FVSG set of items in this situation too (p-value <0.05). Again, the 
asymptotic significance of ROC curves was acceptable for both sets of criteria (p-value <0.001).  
Computer-simulation results are summarized in figure 2. No significant differences were 
observed between the datasets obtained with the two distinct approaches used to generate 
artificial patient data, thus indicating the good robustness and reproducibility of our simulation 
procedures (data not shown). Application of the two sets of criteria to artificially generated data 
suggested a significant relationship between the sparseness and the quality (i.e. in terms of intra-
cluster homogeneity) of the resulting cluster partitions, and the positive-predictive value of the 
sets of criteria used to generate these partitions. Indeed, case partitions obtained with selected 
FVSG items displayed significantly lower sparseness and higher intra-cluster homogeneity than 
those generated with the 1990 ACR criteria (fig 2A and 2B), particularly when used to distinguish 
between PAN and MPA (p-value <0.05). Most notably, the FVSG set of items yielded higher PAN 
predictive performances, in terms of positive-predictive value and sensitivity (fig 2C and 2E), than 
the 1990 ACR criteria (p-value <0.05). This better performance was conserved even when the 
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prevalence of PAN cases in generated patient populations was artificially lowered. The gain in 
PAN predictive ability achieved with the FVSG criteria was not accompanied by any significant 
decrease of the specificity or the negative-predictive value (fig 2D and 2F), as compared to the 
1990 ACR criteria. 
DISCUSSION 
Validated diagnostic criteria for systemic diseases could be a useful tool for clinicians who cannot 
obtain a histological diagnosis or want to avoid taking biopsies due to the risk of side effects. 
Despite inconstant performances reported in the literature (4, 7) many clinicians still 
inappropriately use the 1990 ACR classification criteria for diagnostic purposes. As some analysts 
suggested, a potential explanation for the inconstant results obtained with those criteria for 
diagnostic predictions, could be the dependence of their discriminant abilities on the prevalence 
of individual vasculitides within the analyzed populations (24, 25). Moreover, similar reports 
related to other vasculitis classification systems, like the Chapel Hill Nomenclature (8), showed 
similar unsatisfactory performances when used for diagnostic purposes (5, 6) and highlighted the 
need to develop separate criteria for classification and diagnosis of the various systemic 
vasculitides (7, 26). 
Herein, we reported our analysis of patients data accumulated in the FVSG database that 
targeted two main objectives. The first was to establish a minimal set of non-redundant criteria 
positively or negatively predictive of PAN and potentially useful not only for classification but also 
for diagnostic purposes. The discriminant accuracy of the selected FVSG item set (table 1) was 
evaluated comparatively with that of 1990 ACR criteria on a sample of patients with histologically 
proven systemic vasculitides selected from the FVSG database. The second objective aimed to 
evaluate the PAN-predictive abilities of each of these sets of criteria during a computer-
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simulation procedure relying on an unsupervised hierarchical classification algorithm applied to 
artificially generated patient data. 
The results of our analysis showed that, when applied to the FVSG database, 1990 ACR 
criteria did not confirmed their initially reported PAN discriminant abilities (2). By contrast, the 
selected FVSG item set, established by our analysis, significantly outperformed the 1990 ACR 
criteria, regardless of the analytical situation considered (tables 2 and 3 and fig. 1). The difference 
between the discriminant performances provided by the two sets of criteria was even more 
significant when the analysis was restricted to the subgroup of HBV-negative PAN, which could 
not be distinguished from non-PAN vasculitides by using the 1990 ACR criteria, as shows the 
extremely low sensitivity yielded by these criteria in this particular situation. 
Furthermore, although 7 of the 9 original items of the 1990 ACR criteria (excepted 
histology) were found to have significantly non-redundant usefulness to distinguish PAN from 
other systemic vasculitides in the FVSG database, a significant positive association with PAN 
diagnosis could not be confirmed for three of them (table 3). Moreover, the renal insufficiency, 
which yielded significant discriminant ability to distinguish PAN in our analysis, had a lower 
frequency in PAN patients than in other systemic vasculitides or in MPA (table 3). These findings 
are in agreement with previous reports (4) that indicated low PAN positive-predictive value of the 
1990 ACR criteria. 
As previously suggested, in addition to some epidemiological differences between patient 
samples, another potential explanation for this phenomenon could be the non-distinction 
between PAN and MPA inherent in the 1990 ACR analysis. Indeed, a strong argument supporting 
this hypothesis are the poorly discriminant performances of the 1990 ACR criteria in our analyses 
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when used to distinguish between histologically confirmed PAN and MPA (table 3), which was 
already shown to be a major drawback of these criteria (25, 27, 28). 
Finally, a third possible explanation of the differences in discriminant abilities observed 
between the 1990 ACR criteria and the selected FVSG item set could reside in the methodological 
differences between the two analyses. While the 1990 ACR analysis focused on the selection of 
positive discriminant criteria for classification purposes, our analysis sought to maximize the 
combined predictive relevance of the selected items by considering both positively and negatively 
parameters associated with PAN. Indeed, this strategic difference could potentially explain why 
significant negative discriminant items, as for example the immunofluorescence ANCA positivity, 
could have been missed by the 1990 ACR analysis. The importance of ANCA positivity in vasculitis 
diagnosis was first recognized by the Chapel Hill Nomenclature (8). In our analysis the ANCA 
positivity yielded the strongest discriminant ability, covering 22% of the variance in the logistic-
regression model used to distinguish PAN from other vasculitides, and 50% of the logistic-
regression model variance when used to distinguish PAN from MPA (table 2). It is well-
acknowledged that the IIF ANCA detection provides a lower specificity than the ELISA antigen-
specific techniques (10), and therefore it should be expected that the combination of these two 
detection methods may further improve the discriminant performances of the FVSG item set. 
In the end, the assessment of the relevance of the two sets of criteria to diagnose PAN 
was complemented by a computer-simulation procedure that relied on both sets of items to 
perform an unsupervised classification task on artificially generated patient data. Although the 
numbers of case clusters, contained by the optimal partitions, were not the same as the real 
number of vasculitis entities (e.g. four in our case) represented in the artificial patient samples, in 
either of the considered analytical conditions, the FVSG item set yielded 2–5 times fewer clusters 
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(e.g. closer to the real number of vasculitis entities) than those obtained with the 1990 ACR 
criteria. This lower sparseness of the partitions obtained with the FVSG items was associated with 
significantly better intra-cluster homogeneity of the resulting case clusters than that provided by 
the 1990 ACR criteria, thereby confirming the superior PAN-predictive abilities of the FVSG item 
set. 
Pertinently, the FVSG item set exhibited also significantly stronger robustness when the 
prevalence of vasculitides was artificially varied in generated patient samples, thus suggesting 
better adaptability of this set to various epidemiological conditions. Also the low sensitivities and 
positive predictive values obtained with the 1990 ACR criteria during the computer-simulation 
procedure are in accordance with the high percentages of false-positive PAN diagnoses previously 
reported with this criteria set (4), indicating good reliability of computer-simulation analyses. 
To conclude, the results of the analyses described herein suggest that the combined use 
of positive and negative criteria could significantly improve discriminant performances, while 
providing a more appropriate support for analytical medical reasoning as it examines, with equal 
importance, both positive and negative rationale for considering a diagnosis. Indeed, as the 
results of our computer-simulation suggest, the combination of positive and negative 
discriminant criteria may prove beneficial for the establishment of a diagnostic screening tool for 
vasculitis patients. Further prospective validation of this set of criteria in a multicenter 
international study, including different populations and epidemiological settings, is needed 
before confirming that these items provide a satisfactory diagnostic tool.  
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TABLES AND FIGURES 
Table 1. The FVSG minimal set of low redundant PAN predictive criteria derived from the analysis 
of the FVSG patient database. 
  * Significant positive (+) or negative (−) association with PAN diagnosis in the FVSG patient 
database. 
Table 2. Discriminant performances of a minimal set of low redundant FVSG predictive criteria, to 
distinguish PAN from other systemic vasculitides or MPA in the FVSG patient database: (A) 
considering all PAN cases, and (B) considering only HBV-negative PAN cases. 
  * Stepwise estimation of odds ratio. 
  ** Incremental R² computed at each step of the logistic regression model. 
  *** ENT signs, e.g. maxillary sinusitis or otitis media. 
Table 3. Discriminant performances of significant and non-redundant items of 1990 ACR criteria 
set, to distinguish PAN from other systemic vasculitides or MPA in the FVSG patient database: (A) 
considering all PAN cases, and (B) considering only HBV-negative PAN cases. 
  * Stepwise estimation of odds ratio. 
  ** Incremental R² computed at each step of the logistic regression model. 
  *** Items showing no significant usefulness to distinguish PAN. 
Table 4. Two sets of positive and negative association rules illustrating the potential use of the 
FVSG set of discriminant items to distinguish PAN from other systemic vasculitides or from MPA 
in clinical conditions.  
* 1 indicates the presence of the respective items while 0 indicates their absence 
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** Rule’s precision evaluated on FVSG data. 
*** Number of cases in which the rule was applicable. 
Figure 1. ROC curve analyses comparing PAN discriminant performances of the FVSG set of items 
versus 1990 ACR classification criteria to identify PAN in two situations: (A) considering all 
systemic vasculitides as controls; and (B) restricting controls at MPA cases. 
Figure 2. Results of computer simulations evaluating the potential usefulness of FVSG 
discriminant set of items compared to 1990 ACR criteria to diagnose PAN. Artificial patient data 
were generated by relying on the Bahadur–Lazarsfeld extension, either respecting the reported 
French prevalence (FVSG  or ACR ) of the four main types of vasculitides (PAN, WG, CSS, 
MPA), or after arbitrarily modifying them to low PAN (FVSG  or ACR ). The box plots report 
the median (horizontal line within the box), the first and the third quartiles (the upper and lower 
limits of the box), and the range (T bars), computed from 30 consecutive iterations of the 
simulation procedure (see text for detailed explanations). 
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Table 1. The FVSG minimal set of low redundant PAN predictive criteria derived from the analysis of the FVSG patient database. 
Criterion PAN Association* Definition 
1. HBV  infection (+) 
Markers reflecting active HBV replication such as the presence of HBeAg in serum and/or 
the detection of HBV DNA >105 copies/mL 
2. ANCA positivity (−) ANCA presence in serum tested by indirect immunofluorescence 
3. Asthma (−) Personal antecedents of asthma 
4. ENT signs (−) Maxillary sinusitis or otitis media signs 
5. Cryoglobulin positivity (−) Cryoglobulin detection in serum 
6. Glomerulopathy (−) 
Glomerulopathy signs such as proteinuria and/or hematuria with or without renal 
insufficiency, not dues to urinary tract infections, urolithiasis, hematologic or other non-
glomerular causes 
7. 
Arteriographic 
anomalies 
(+) 
Arteriogram showing aneurysms or occlusions of the visceral arteries, not due to 
arteriosclerosis, fibromuscular dysplasia, or other non-inflammatory causes 
8. Mono-/polyneuropathy (+) Development of mononeuropathy, multiple mononeuropathies, or polyneuropathy 
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Table 2. Discriminant performances of a minimal set of low redundant FVSG predictive criteria, to 
distinguish PAN from other systemic vasculitides or MPA in the FVSG patient database: (A) 
considering all PAN cases, and (B) considering only HBV-negative PAN cases. 
A) FVSG discriminant items Odds ratio [95% CI]* R²** 
PAN/Other vasculitides   
1 (+) HBV  infection (active replication) 16.41 [7.34–36.68] 0.323 
2 (−) ANCA positivity 0.04 [0.02–0.08] 0.539 
3 (−) Asthma 0.10 [0.04–0.21] 0.598 
4 (−) ENT signs*** 0.09 [0.03–0.25] 0.629 
5 (−) Cryoglobulin positivity 0.13 [0.04–0.40] 0.644 
6 (−) Glomerulopathy 0.36 [0.22–0.58] 0.656 
7 (+) Arteriographic anomalies 3.48 [1.68–7.22] 0.668 
8 (+) Mono-/polyneuropathy 1.87 [1.19–2.94] 0.674 
PAN/MPA   
1 (−) ANCA positivity 0.03 [0.01–0.08] 0.508 
2 (+) HBV infection (active replication) 18.40 [6.10–55.51] 0.607 
3 (−) Glomerulopathy 0.19 [0.10–0.33] 0.648 
4 (+) Arteriographic anomalies 6.13 [2.13–17.65] 0.669 
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B) FVSG discriminant items Odds ratio [95% CI]* R²** 
HBV-negative PAN/Other vasculitides   
1 (−) ANCA positivity 0.02 [0.01–0.07] 0.336 
2 (−) Asthma 0.10 [0.04–0.23] 0.427 
3 (−) ENT signs*** 0.10 [0.03–0.29] 0.468 
4 (−) Glomerulopathy 0.37 [0.23–0.61] 0.485 
5 (−) Cryoglobulin positivity 0.19 [0.06–0.56] 0.503 
6 (+) Arteriographic anomalies 3.18 [1.49–6.77] 0.515 
HBV-negative PAN/MPA   
1 (−) ANCA positivity 0.02 [0.01–0.07] 0.495 
2 (−) Glomerulopathy 0.18 [0.10–0.33] 0.556 
3 (+) Arteriographic anomalies 5.61 [1.86–16.89] 0.581 
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Table 3. Discriminant performances of significant and non-redundant items of 1990 ACR criteria 
set, to distinguish PAN from other systemic vasculitides or MPA in the FVSG patient database: (A) 
considering all PAN cases, and (B) considering only HBV-negative PAN cases. 
A) 1990 ACR criteria Odds ratio [95% CI]* R²** 
PAN/Other vasculitides   
1 (+) HBV infection 25.53 [13.67–47.67] 0.323 
2 (+) Arteriographic anomalies 4.40 [2.43–7.95] 0.356 
3 (−) Renal insufficiency 0.31 [0.18–0.56] 0.377 
4 (+) Livedo reticularis 2.11 [1.24–3.58] 0.387 
5 (+) Mono-/polyneuropathy 1.69 [1.16–2.46] 0.397 
6 (+) Testicular pain or tenderness 3.12 [1.19–8.20] 0.402 
7 (+) Diastolic BP >90 mmHg 1.66 [1.06–2.61] 0.408 
8*** Weight loss ≥4 kg 0.75 [0.52–1.08] - 
9*** Myalgias 1.40 [0.98–2.00] - 
PAN/MPA   
1 (+) HBV infection 21.21 [8.17–55.09] 0.293 
2 (−) Renal insufficiency 0.13 [0.07–0.25] 0.380 
3 (+) Arteriographic anomalies 7.45 [2.94–18.86] 0.427 
 
 
H
AL author m
anuscript    inserm
-00276487, version 1
  
27 
B) 1990 ACR criteria Odds ratio [95% CI]* R²** 
HBV-negative PAN/Other vasculitides   
1 (+) Arteriographic anomalies 4.42 [2.38–8.21] 0.043 
2 (−) Renal insufficiency 0.27 [0.15–0.51] 0.080 
3 (+) Livedo reticularis 2.07 [1.21–3.55] 0.095 
4 (+) Myalgias 1.55 [1.07–2.25] 0.108 
5 (+) Diastolic BP >90 mmHg 1.69 [1.06–2.71] 0.116 
6***  Testicular pain or tenderness 2.69 [0.98–7.41] - 
7*** Weight loss ≥4 kg 0.72 [0.50–1.05] - 
8*** Mono-/polyneuropathy 1.45 [0.99–2.15] - 
HBV-negative PAN/MPA   
1 (−) Renal insufficiency 0.13 [0.07–0.26] 0.147 
2 (+) Arteriographic anomalies 6.99 [2.68–18.20] 0.209 
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Table 4. Two sets of positive and negative association rules illustrating the potential use of the 
FVSG set of discriminant items to distinguish PAN from other systemic vasculitides or from MPA 
in clinical conditions. 
Rules* Confidence** Cases*** 
PAN/Other vasculitides: positive PAN association   
1. If  HBV = 1 and arteriographic anomalies = 1 then PAN = 1 100% 31 
2. If  HBV = 1 and ANCA = 0 and neuropathy = 1 then PAN = 1  97% 96 
3. 
If  HBV = 1 and cryoglobulin = 0 and glomerulopathy = 0 and  ENT signs = 
0 then PAN = 1 
96% 80 
4. 
If  ANCA = 0 and arteriographic anomalies = 1 and  ENT signs = 0 then PAN 
= 1  
79% 66 
PAN/Other vasculitides: negative PAN association   
1. If  HBV = 0 and ANCA = 1 then PAN =  0 99% 401 
2. 
If  ANCA = 1 and glomerulopathy = 1 and arteriographic anomalies = 0 
then PAN = 0 
99% 270  
3. If  ENT signs = 1 then PAN = 0 98% 253 
4. If  neuropathy = 0 and arteriographic anomalies = 0 then PAN = 0 86% 377 
5. If  HBV = 0 and arteriographic anomalies = 0 then PAN = 0  83% 779 
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PAN/MPA: positive PAN association   
1. If  HBV = 1 and ANCA = 0 then PAN = 1 96% 108 
2. If  ANCA = 0 and arteriographic anomalies = 1 then PAN = 1 93% 57 
3. If  ANCA = 0 and glomerulopathy = 0 then PAN = 1 86% 221 
PAN/MPA: negative PAN association   
1. If  ANCA = 1 then PAN = 0  94% 138 
2. 
If  HBV = 0 and glomerulopathy = 1 and arteriographic anomalies = 0 then 
PAN = 0 
85% 161 
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Figure 2  
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